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Abstract
Background
Third trimester fetal growth is partially regulated by C-peptide and insulin-like growth factor I
(IGF-I). Prenatal exposures including maternal obesity and high gestational weight gain as
well as high birth weight have been linked to subsequent metabolic disease. We evaluated
the associations between newborn regional body composition and cord blood levels of C-
peptide and IGF-I.
Methods
We prospectively included obese and normal-weight mothers and their newborns; cord
blood was collected and frozen. Analyses of C-peptide and IGF-I were performed simulta-
neously, after recruitment was completed. Newborn regional body composition was
assessed with dual-energy X-ray absorptiometry scanning (DXA) within 48 hours of birth.
Results
Three hundred thirty-six term infants were eligible to participate in the study; of whom 174
(52%) infants had cord blood taken. Total, abdominal and arm and leg fat mass were posi-
tively associated with C-peptide (p < 0.001). Arm and leg fat mass was associated with IGF-
I concentration: 28 g [95% confidence interval: 4, 53] per doubling of IGF-I. There was no
association between total or abdominal fat mass and IGF-I. Fat-free mass was positively
associated with both C-peptide (p < 0.001) and IGF-I (p = 0.004).
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Conclusion
Peripheral fat tissue accumulation was associated with cord blood C-peptide and IGF-I. Total
and abdominal fat masses were related to C-peptide but not to IGF-I. Thus, newborn adipos-
ity is partially mediated through C-peptide and early linear growth is associated with IGF-I.
Introduction
The prevalence of childhood obesity has increased dramatically during the last decades in high
as well as low income settings [1]. The prenatal and early postnatal periods have been identified
as sensitive periods during which the susceptibility of developing obesity is affected by genetic,
epigenetic, and environmental factors [2–5].
The offspring of obese mothers have an increased risk of becoming obese compared to off-
spring of normal-weight mothers [6]. A less favorable intrauterine environment may play an
important role in development of obesity [7,8]. Increased pre-pregnancy body mass index (BMI),
excessive gestational weight gain (GWG), and elevated glucose levels are known to independently
influence fetal growth and tissue composition, and to increase the risk of subsequent develop-
ment of obesity [9–13]. Thus maternal phenotype and life style may contribute to a vicious trans-
generational cycle in which the risk of obesity is acquired through both genetics and exposures.
Population-based preventive strategies against childhood obesity seem less promising [14],
and therefore detailed knowledge about risk factors is imperative in order to design future
interventional studies targeting childhood obesity [4].
Insulin and insulin-like growth factor I (IGF-I) are the most important growth factors in
the regulation of second and third trimester fetal growth [15]. C-peptide may be used as a
proxy for insulin in cohort studies since it is more stable than insulin [16]. Fetal C-peptide is
related to maternal glycemic control during pregnancy [17], a theory originally proposed by
Pedersen et al. in 1952. Glucose transverses the placenta and promotes insulin (and C-peptide)
secretion in the fetus [18,19]. Female sex, high birth weight, and adiposity have been linked to
an elevated concentration of C-peptide in newborns [17]. C-peptide stimulates the release of
IGF-I in the fetus [20]. IGF-I is a polypeptide that affects cellular proliferation and differentia-
tion and has in previous studies been positively associated with female sex, birth weight, and
birth length [15,21,22]. IGF-I may influence fat cell differentiation, an in vitro study found that
the differentiation of visceral fat cells is strongly associated with IGF-I than with subcutaneous
fat cells [23]. Whereas fetal C-peptide is modifiable through maternal glucose levels, IGF-I is
more constant and to a wider extent genetically determined [24].
Fetal levels of anabolic hormones may be the common pathway between the intrauterine
environment and body composition in the newborn and subsequent risk of metabolic disease
[6,9,25]. This is the first study to evaluate the association between newborn regional body com-
position and cord blood levels of C-peptide and IGF-I. We hypothesize that the amount of
abdominal fat mass is primarily associated with IGF-I and that the other fat mass depots (arm
and leg fat mass) are closer associated with C-peptide
Methods
Study design
Obese (n = 130) and normal-weight (n = 44) mothers and their offspring were included in the
study. Obese mothers were recruited at the time of the first ultrasound examination in
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gestational week 11–13 in the Treatment of Obese Pregnant (TOP) study at Hvidovre Hospital,
Copenhagen University (reported in detail elsewhere [26]). The TOP study inclusion criterion
was a pre-pregnancy BMI above or equal to 30 kg/m2, and the obese pregnant women were
encouraged to keep GWG below 5 kg. Obese mothers were randomized to: PA+D: physical
activity intervention assessed by pedometer and diet, PA: physical activity intervention
assessed by pedometer or C: control (the control group was also advised to limit GWG accord-
ing to the TOP-study recommendation). The TOP study included a total of 425 women.
Recruitment for this study was initiated 1 year and 7 months after the TOP study started at
which time 135 women had already given birth, leaving 284eligible for inclusion in the present
study.
The group of normal weight mothers was selected on 15 random days from the group of
pregnant women visiting the maternity ward for routine check-ups in the third trimester and
who were not in labor. Normal weight was defined as a self-reported pre-pregnancy BMI
between 18.5–24.9 kg/m2.
We included healthy, newborn, singleton infants born at term (>258 days of gestation), and
with a postnatal age< 48 hours. Infants were recruited between December 10, 2010 and June
30, 2012. We excluded mothers with a chronic disease and pre-eclampsia. In Denmark, gesta-
tional diabetes mellitus (GDM) is defined as 2-h glucose> 8.9 mmol/l [27]. Women diagnosed
with GDM were excluded. Infants requiring admission to a neonatal intensive care unit or suf-
fering from congenital diseases or malformations were excluded.
Maternal data. Information on maternal educational and smoking status, exercise habits,
and any previous pregnancies was collected from a questionnaire filled in during the first tri-
mester survey for obese mothers and during the third trimester for normal-weight mothers.
Gestational age was determined through an early ultrasound examination (gestational week
11–13).
Pre-pregnancy weight was self-reported. All women were weighed at the hospital wearing
light clothing and no shoes at 36–37 week of gestation (Seca digital scales, Germany). GWG
was calculated as the difference between pre-pregnancy weight and weight at 36–37 weeks of
gestation. GWG was categorized based on Institute of Medicine’s (IOM) criteria into inade-
quate, adequate, or excessive weight gain. Adequate GWG is 5–9 kg for pre-pregnancy obese
and 11.5–15.9 for pre-pregnancy normal weight [28]. Mode of delivery was categorized as vagi-
nal delivery, assisted vaginal delivery, acute caesarean section and elective caesarean section.
Infant data. The newborns were weighed recumbent on an infant scale (Seca 727, digital
baby scales Germany). Length and head circumference were measured with non-stretchable
measuring tape according to WHO guidelines [29]. Abdominal circumference was measured
by non-stretchable measuring tape during mid-expiration at the umbilical level in the supine
position.
Body composition assessment. Infant body composition was assessed using dual-energy
X-ray absorptiometry (DXA) scanning (DXA, Hologic 4500, Bedford, MA, USA) within 48
hours after birth. Through this method information on fat and fat-free body mass as well as
bone mass was obtained. When evaluating the scans, we used the same criteria as Cooke et al.
[30], and only scans that met predefined quality criteria were included in the analysis. Fat
mass/total mass was used to calculate fat%.
Abdominal fat mass and fat-free mass were estimated by identifying two abdominal
regions using Pediatric DXA software from Hologic. The first region was limited by the tho-
racic diaphragm and both upper iliac crests, the second region was limited laterally by the
upper iliac crests and caudally by the femoral heads, and the total sum of the two regions con-
stituted the abdominal region. Arm and leg fat mass were calculated by defining all four
extremities as regions and thereafter calculating a total mass. From duplicate scans in 58
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infants, the test-retest variability concerning DXA-derived fat and fat-free mass was calculated
to 11.8% and 7.1%, respectively (data not shown).
Birth weight z-score is birth weight adjusted for gestational age and sex and was calculated
using Marsal et al. as normal reference [31].
Cord blood samples. Cord blood samples were obtained immediately after birth and after
clamping the umbilical vein, only vein blood was obtained. The blood was not milked. Samples
were obtained by the staff at the maternity ward. Samples were sent for immediate centrifuga-
tion, and the plasma was separated and stored at -80°C until analyses were performed. C-pep-
tide and IGF-I were analyzed as a batch using an Immulite 1000 Analyzer (Diagnostic
Products Corporation, Los Angeles, CA, USA) with kits from Siemens, (Siemens healthcare,
Germany). The detection limit for IGF-I was 25 ng/mL. Values below the detection limit were
coded 24 ng/mL (to diminish variance); this was the case in 14 samples. If extensive hemolysis
was present, C-peptide was not analyzed due to the uncertainty this imposes (seven samples
were excluded due to hemolysis).
Ethics. Informed written consent was obtained from both parents before infants were
included in the study, and the Ethics Committee of the Capital Region of Denmark (H-D-
2008-119) approved the study. The study was registered at www.clinicaltrials.gov
(NCT01235676) and performed according to the Helsinki II declaration.
Statistical analysis. Overall baseline characteristics for pre-pregnancy obese mothers and
normal-weight mothers and their offspring are presented as mean with standard deviation
(SD), median with range, or proportions, (Table 1). Differences in cord blood hormones
between sexes and adjusted for gestational age were calculated by multiple regression. C-
peptide and IGF-I were transformed using the natural logarithm to obtain homogeneity of var-
iances. The correlation between C-peptide and IGF-I was assessed using Spearman’s correla-
tion. The influence of TOP-study randomization on C-peptide and IGF-I and newborn
anthropometrics were assessed using multiple regression analyses, the models were adjusted
for maternal age, pre-pregnancy BMI, GWG, parity, smoking, education, mode of delivery, ges-
tational diabetes mellitus, newborn gestational age, and sex.
Multiple linear regressions was used to evaluate the effect of C-peptide and IGF-I on birth
weight z-score, newborn body composition, newborn fat mass, fat-free mass, fat%, abdominal
fat mass, and arm and leg fat mass. All models are presented as raw values adjusted for new-
born sex and gestational age or fully adjusted for maternal age, pre-pregnancy BMI, GWG, par-
ity, smoking, education, mode of delivery, newborn gestational age, and sex.
To determine whether maternal factors (pre-pregnancy obesity, GWG, and parity) influ-
enced cord blood C-peptide and IGF-I concentrations, multiple linear regression analysis was
performed, fully adjusted for maternal age, smoking, education, mode of delivery, newborn
gestational age, and sex. IGF-I concentration was also adjusted for C-peptide levels. The level
of significance was set to 0.05 (SPSS Statistics, version 19.0, Chicago, IL, USA).
Results
In total 336 were eligible for inclusion and of these 174 (52%) were included and had cord
blood samples taken (Figs 1 and 2).
There were no differences in pre-pregnancy BMI, GWG, and fetal birth weight between the
participants who had cord blood taken compared to those who did not. Concentrations of C-
peptide were positively correlated to the concentrations of IGF-I (r = 0.15, p = 0.044).
The TOP-study randomization did not affect cord blood concentration of C-peptide and
IGF-I (data not shown) nor did it affect newborn anthropometric measurements [32].
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Table 1. Baseline characteristics, maternal and newborn, grouped according to maternal pre-pregnant bodymass index (BMI) (kg/m2).
Maternal characteristics Obese mothers Normal weight mothers p value
n = 130 n = 44
Maternal age (years) 1 31.0 (4.4) 31.2 (4.6) 0.75
Pre-pregnant BMI (kg/m2) 2 34.4 (30.0–50.3) 22.2 (19.0–24.9) < 0.001
Gestational weight gain (kg) 1 10.1 (6.3) 14.1 (3.6) < 0.001
IOM GWG categories (n) 3
Inadequate 29 11
Adequate 33 24
Excessive 68 9 < 0.001
Primiparas (%)3 61 66 0.92
Maternal education (years) 1 14.5 (2.3) 15.1 (2.3) 0.14
Maternal smoking (%)3 10 7 0.53
Mode of delivery
Vaginal 76 26
Assisted Vagnial 13 4
Acute ceaseran section 26 4
Elective ceaseran section 15 10 0.16
Newborn characteristics
Birth weight (g) 1 3728 (525) 3572 (462) 0.082
Birth length (cm) 1 52.7 (2.3) 51.9 (2.0) 0.043
Head circumference (cm) 1 35.4 (1.6) 34.8 (1.7) 0.037
Abdominal circumference (cm) 1 33.7 (2.1) 33.4 (1.8) 0.33
Sex 3
Male (%) 55 45
Female (%) 45 55 0.29
Gestational age at birth (days) 1 281 (9) 281 (8) 0.74
Birth weight z-score *1 0.30 (1.20) -0.05 (0.86) 0.041
Fat-free mass (g) 1 3404 (399) 3390 (393) 0.85
Fat mass (g) 1 436 (221) 342 (163) 0.01
Fat (%)1 11.0 (4.4) 8.9 (3.5) 0.004
Abdominal fat mass (g) 1 57 (31) 42 (22) 0.001
Arm and leg fat mass (g) 1 232 (113) 176 (76) <0.001
IGF-I (ng/mL) 1 71.5 (31.8) 67.0 (24.7) 0.35
Log IGF-I1 4.2 (0.5) 4.1 (0.4) 0.70
C-peptide (pmol/l)2 442 (76–1427) 396 (102–1526) 0.13
Log C-peptid1 5.9 (0.6) 5.8 (0.6) 0.19
Apgar (5 min)2 10 (7–10) 10 (8–10) 0.35
Birth weight > 4000 g3% (n) 23 (10) 29 (38) 0.40
Birth weight < 2500 g3% (n) 0 (0) 2 (3) 0.30
1 Mean (±SD), Student’s t-test
2 Median (range), Mann-Whitney test
3Proportion, chi-square test
*Birth weight adjusted for gestational age at birth and sex, according to Marsal et al.
doi:10.1371/journal.pone.0121350.t001
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Clinical characteristics of obese versus pre-pregnancy normal-weight
mothers and their offspring
A larger proportion of pre-pregnancy obese mothers had an excessive GWG as defined by
IOM [28], but mean GWG was lower in the obese than in the normal weight mothers
(p< 0.001), (Table 1). Except for the pre-pregnancy BMI and GWG, there were no other dif-
ferences in baseline characteristics between obese and normal-weight mothers.
The infants of the obese mothers had a higher mean birth weight z-score of 0.35, (p = 0.041)
and a greater mean fat mass of 94 g (p = 0.001) than offspring of normal-weight mothers.
There was no difference in newborn fat-free mass (p = 0.85) (Table 1). IGF-I concentrations
Fig 1. Study inclusion pre-pregnancy obese women.When too little cord blood was obtained, it was not possible to analyze C-peptide and IGF-I.
doi:10.1371/journal.pone.0121350.g001
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were higher in female infants (p = 0.014), whereas there was no differences in C-peptide con-
centrations between the sexes. (Table 2).
Newborn regional body composition versus C-peptide and IGF-I
Birth weight z-score and birth length were positively associated with both C-peptide and
IGF-I. Total fat mass, abdominal fat mass, and arm and leg fat mass were significantly related
to C-peptide, both unadjusted and adjusted. Per doubling of the concentration of C-peptide,
fat % increased by 1.3%, [95% confidence interval (CI): 0.6, 2.0], (p< 0.001). In contrast, only
arm and leg fat mass but not the abdominal fat mass was related to IGF-I concentration. Per
Fig 2. Study inclusion pre-pregnancy normal weight women.When too little cord blood was obtained, it was not possible to analyze C-peptide and IGF-I.
doi:10.1371/journal.pone.0121350.g002
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doubling of IGF-I concentration, the adjusted arm and leg fat mass increased by 28g [95% CI:
4, 53] (p = 0.023), but fat % was not associated with cord blood IGF-I levels.
Newborn fat-free mass was related to the concentration of C-peptide and IGF-I; per dou-
bling of C-peptide fat-free mass increased with 157 g [95% CI: 95, 219] and per doubling of the
concentration of IGF-I, the fat-free mass increased with 121 g [95% CI: 39, 204]. These analyses
were adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode
of delivery and newborn gestational age and sex (Tables 3, 4, 5, and 6).
C-peptide and IGF-I versus maternal factors
The concentration of C-peptide was positively associated with GWG and pre-pregnancy obe-
sity. Per kg increase in GWG, C-peptide rose by a mean of 2.2% [95% CI: 0.7, 3.7]. In obese
women, C-peptide increased by 22.1% [95% CI: 1.7, 42.5]. IGF-I was not associated with GWG
or obesity. IGF-I were inversely associated with parity and levels were 29.1% lower in primipa-
ras [95% CI: -43.0, -15.0] (Table 7).
Discussion
This is the first study to evaluate the association between cord blood C-peptide and IGF-I and
newborn regional body composition assessed by DXA. Newborn fat-free mass was positively
associated with C-peptide and IGF-I concentrations, and furthermore total fat mass and
abdominal and arm and leg fat mass were positively associated with C-peptide. These associa-
tions were still present after adjustment for maternal factors such as age, education, smoking,
parity, pre-pregnancy BMI and GWG. Our primary finding was, however, the divergent effect
Table 2. Cord blood concentration of c-peptide and IGF-I, presented stratified by sex.
Boys (n = 91) Girls (n = 83) p value
C-peptide (pmol/l)1 374 (76–1427) 387 (97–1526) 0.38
Log C-peptide2 5.9 (0.5) 6.0 (0.6) 0.31
IGF-I (ng/mL) 2 65.0 (26.4) 76.2 (33.0) 0.014
Log IGF-I2 4.1 (0.4) 4.2 (0.5) 0.037
1 Median (range)
2 Mean (±SD), Student’s t-test
doi:10.1371/journal.pone.0121350.t002
Table 3. The association between birth weight (z-score) and newborn fat (%) and C-peptide and IGF-I.
Dependent
Birth weight (z-score) Birth weight (z-score) Fat (%) Fat (%)
(Unadjusted) (Fully adjusted*) (Partly adjusted**) (Fully adjusted***)
ß [95% CI] p value ß [95% CI] p value ß [95% CI] p- value ß [95% CI] p-value
Independents
Constant -8.0 -12.2 -34 -51
C-peptide1 0.8 [0.6, 1.1] <0.001 0.6 [0.4, 0.8] <0.001 2.4 [1.3, 3.4] <0.001 1.9 [0.8, 2.9] <0.001
IGF-I1 0.8 [0.5, 1.1] <0.001 0.4 [0.1, 1.6] 0.005 0.8 [-0.6, 2.1] 0.26 0.9 [-0.5, 2.2] 0.20
1 Log-values
*Adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode of delivery and birth length
**Adjusted for gestational age and sex
***Adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode of delivery and newborn gestational age and sex
doi:10.1371/journal.pone.0121350.t003
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of IGF-I: arm and leg fat mass was positively associated with IGF-I, but there was no associa-
tion between IGF-I and abdominal fat mass or total fat mass.
Newborn regional body composition versus IGF-I and C-peptide
The finding of higher birth weights in association with higher cord blood levels of both C-pep-
tide and IGF-I has previously been demonstrated [17,21]. IGF-I is important for normal fetal
growth and may be a mediator related to development of childhood obesity and non-commu-
nicable diseases in adulthood [15,33–35]. The association between newborn regional body
composition and IGF-I is unknown, and previous studies on the association between fetal fat
mass and IGF-I are contradictive [36,37]. Another study in which body composition was
assessed within 2 weeks of birth using DXA to assess newborn body composition found total
fat mass to be related to IGF-I in 119 newborns [36]. In contrast, Beltrand et al. examined a
cohort of neonates who were at risk of low birth weight and observed that newborn fat mass
was closely associated with insulin levels, whereas no association was seen between fat mass
and IGF-I. Despite data on regional body composition, there are no analyses on the association
between regional fat distribution and cord blood insulin and IGF-I [37].
Table 4. The association between newborn total fat-free mass and fat mass and C-peptide and IGF-I.
Dependent
Fat-free mass (g) Fat-free mass (g) Fat mass (g) Fat mass(g)
(Partly adjusted*) (Fully adjusted**) (Partly adjusted*) (Fully adjusted**)
ß [95% CI] p value ß [95% CI] p value ß [95% CI] p- value ß** [95% CI] p-value
Independents
Constant -2963 -3058 -2266 -3030
C-peptide1 226 [137, 315] <0.001 227 [137, 317] <0.001 135 [84, 185] <0.001 111 [61, 161] <0.001
IGF-I1 236 [124, 349] <0.001 176 [56, 295] 0.004 48 [-16, 112] 0.14 45 [-21, 111] 0.18
1 Log-values
*Adjusted for gestational age and sex
**Adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode of delivery and newborn gestational age and sex
doi:10.1371/journal.pone.0121350.t004
Table 5. The association between arm and leg fat mass and abdominal fat mass and C-peptide and IGF-I.
Dependent
Abdominal Fat
mass (g)
Abdominal Fat
mass (g)
Arm and Leg Fat
Mass (g)
Arm and Leg Fat
Mass (g)
(Partly adjusted*) (Fully adjusted**) (Partly adjusted*) (Fully adjusted**)
ß [95% CI] p
value
ß [95% CI] p
value
ß [95% CI] p-
value
ß [95% CI] p-
value
Independents
Constant -263 -364 -1094 -1197
C-peptide1 16 [9,24] <0.001 13 [6,21] 0.001 68 [40, 92] <0.001 57 [31, 83] <0.001
IGF-I1 2 [–8,11] 0.75 0.4 [–9,10] 0.93 48 [13, 82] 0.007 41 [6, 77] 0.023
1 Log-values
*Adjusted for gestational age and sex
**Adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode of delivery and newborn gestational age and sex
doi:10.1371/journal.pone.0121350.t005
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A priori, we hypothesized that the amount of abdominal fat mass would be associated with
cord blood concentrations of IGF-I. This hypothesis was based on an vitro study of fat cells
from 6-year-old children in whom the differentiation of visceral fat cells was more strongly
associated with IGF-I concentration than the differentiation of subcutaneous fat cells [23]
However, our findings point in the opposite direction, indicating that the effect of IGF-I on fat
cells may be different in utero compared to childhood, and we propose that IGF-I stimulates
peripheral fat tissue accumulation.
There are common denominators between third trimester intrauterine growth and growth
between 0 and 6 months. Ong et al. report that infant linear growth (fat-free mass and length
gain) is primarily associated with IGF-I and propose that infant adiposity is associated with
insulin levels or other undetermined factors, and our observations support this view [38].
C-peptide and IGF-I versus maternal factors
In our study, maternal obesity affected cord blood levels of C-peptide but not IGF-I, whereas
cord blood C-peptide was related to GWG. Birth weight has previously been found to be asso-
ciated with GWG [28] and with both maternal insulin sensitivity and the cord blood
Table 6. The association between birth length and C-peptide and IGF-I.
Dependent
Birth length (cm) Birth length (cm)
(Partly adjusted*) (Fully adjusted**)
ß [95% CI] p value ß [95% CI] p value
Independents
Constant 23.27 20.6
C-peptide1 0.89 [0.34, 1.45] 0.002 0.83 [0.27, 1.40] 0.004
IGF-I1 0.90 [0.20, 1.60] 0.012 0.81 [0.06, 1.56] 0.034
1 Log-values
*Adjusted for gestational age and sex
**Adjusted for maternal age, education, smoking, parity, pre-pregnancy BMI, GWG, mode of delivery and newborn gestational age and se
doi:10.1371/journal.pone.0121350.t006
Table 7. The association between cord blood concentrations of C-peptide and IGF-I andmaternal pre-pregnancy obesity, GWG, and primiparity.
Dependents
C-peptide1 * IGF-I1 **
ß [95% CI] p value ß [95% CI] p value
Independents
Constant 5.3 6.13
Pre-pregnancy obesity 0.22 [0.017, 0.43] 0.034 0.041 [-0.11, 0.20] 0.60
GWG 0.022 [0.007, 0.037] 0.004 0.006 [-0.005, 0.018] 0.27
Primiparity 0.032 [-0.15, 0.22] 0.73 -0.29 [-0.43,- 0.15] <0.001
1 Log-values
*Adjusted for maternal age, education, smoking, mode of delivery and newborn gestational age and sex.
**Adjusted for maternal age, education, smoking, mode of delivery and newborn gestational age, sex, and cord blood log C-peptide.
doi:10.1371/journal.pone.0121350.t007
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concentration of C-peptide [17]. Hence, the effect of GWG on cord blood C-peptide is likely to
be mediated through maternal glucose. We have found no previous reports on the association
between GWG and cord blood C-peptide.
We found clear differences in the body composition of the offspring of obese versus nor-
mal-weight mothers. A study has shown that maternal third trimester insulin-like growth fac-
tor-binding protein 1(IGFBP-1) was inversely associated with maternal pre-pregnancy BMI.
Low concentrations of IGFBP-1 increase the bioavailability of maternal IGF-I, which increases
placental nutrient transportation [39]. However, we suggest that newborn body composition is
directly associated with pre-pregnancy obesity, and the effect is mediated not only through
fetal IGF-I because we found no association between cord blood IGF-I and pre-pregnancy obe-
sity. IGF-I concentration was lower in primiparas than in multiparas as reported by Vatten
et al. The reason for this is not fully understood but may be related to a relative placental dys-
function in primiparas [21].
Strengths and limitations
Due to failure to obtain cord blood samples, our cohort was limited to 174 cases, and this may
induce a type II error. Our cohort was primarily recruited through the TOP study. The mater-
nal TOP study intervention did not affect newborn body composition [32] nor did it affect
cord blood concentration of C-peptide and IGF-I (data not shown). However, it is possible that
the women who participated in this study had a general awareness regarding health issues that
would not have been present if the cohort was randomly recruited [40]. It also may affect out-
come that the normal weight women did not receive any intervention. Limitations to our study
were that the obese mothers filled out the baseline questionnaires during the first trimester and
normal-weight mothers during the third trimester and pre-pregnancy weight was self-reported
in both obese and normal weight women.
Our cohort is rather homogenous, and this reduces the risk of bias. Our cohort consisted
primarily of neonates with an increased risk of high birth weights. Fetal IGF-I is closely related
to fetal weight, and therefore the relatively high mean birth weight in our cohort may be impor-
tant when interpreting our results.
It is not possible to differentiate between subcutaneous and visceral fat mass with a DXA
scan. It has been shown previously that DXA-estimated abdominal fat mass can be used as a
proxy for visceral fat mass in cohort studies, although the method is less precise than magnetic
resonance imaging [41,42]. This differentiation is important since it is the visceral fat mass that
is linked to the development of the metabolic syndrome. Cooke et al. have used DXA to assess
regional body composition in preterm and term born infants and determined intra-operator
variability to approximately 1% [30]. There are no studies in newborns validating the use of
DXA to assess regional body composition. We, however, used the same method as Cooke at al.,
and only included the scan if the paired weight between arm and legs agreed (±10%).
The concentration of cord blood hormones is affected by delivery. All participants in our
study had deliveries without major newborn complications. Asphyxia is known to affect IGF-I,
but no asphyctic newborns were included [43]. There were no statistical differences in mode of
delivery between obese and normal weight women. All analyses were adjusted for mode of
delivery.
Conclusion
In this cohort of healthy newborns with obese and normal weight mothers both peripheral and
central fat mass was associated with cord blood C-peptide. Fat-free mass and arm and leg fat
mass were associated with cord blood IGF- I, whereas there was no association between the
Newborn Regional Body Composition and Cord Blood C-Peptide and IGF-I
PLOS ONE | DOI:10.1371/journal.pone.0121350 July 7, 2015 11 / 14
amount of abdominal fat mass and IGF-I. Hence, C-peptide may be a mediator of newborn
adiposity whereas IGF-I levels are mainly related to linear growth. The long-term implications
of these associations need to be explored in further studies.
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